What New Garden Pharma does

New Garden Pharma is the EU GMP-certified medical cannabis extraction and processing subsidiary of New Garden Group, a privately held vertically integrated cannabis operator headquartered in Berlin, Germany. The Skopje, North Macedonia facility occupies a 1.1 hectare site with 2,400 square meters of clean rooms and administration and production capacity of up to 5 liters of distillate per day, expandable. Core technology is CO2 extraction combined with high-end distillation for full-spectrum distillates enriched with natural terpenes, plus an EU GMP-compliant in-house quality control laboratory and stability study services. The facility converts GACP starting material into EU GMP-compliant herbal product and produces cannabis API (Active Pharmaceutical Ingredients) and FDF (Final Dosage Forms), including flowers, extracts, distillates, and isolates, for pharmaceutical and medicinal clients across Europe.

The company operates four sub-brands: New Garden Pharma (medical cannabis CDMO and B2B API/FDF), Herbliz Berlin (consumer CBD oils, cosmetics, vapes, and wellness products), Herbliz Whitelabel (ISO 9001-certified white and private label manufacturing for B2B clients in Europe and Asia, including China), and Herbliz Supplements (nutritional supplements using proprietary liposomal technology that delivers up to 22-fold increased bioavailability for fat-soluble active ingredients). Revenue derives from a mix of B2B contract manufacturing services (GACP/GMP conversion, custom formulation, processing, packaging), white and private label production, and direct-to-consumer CBD and supplement sales via the Herbliz e-commerce storefront. The GTM motion is enterprise field sales for the pharma and white label segments, with quote-based pricing and no publicly disclosed price list. Geographic reach spans Germany, North Macedonia, Austria, France, the UK, Belgium, the Netherlands, and China, with the company positioning itself as a fast route to the EU cannabis market for both medical and wellness applications.

Name

New Garden Pharma

Legal name

New Garden Group

Website

https://newgardengroup.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

New Garden Pharma is a Berlin-headquartered, EU GMP-certified cannabis operator running a Skopje facility for medical cannabis extraction and CDMO, with consumer CBD (Herbliz Berlin), white label manufacturing, and liposomal supplements under the New Garden Group umbrella.

Ownership category

akta.pro rank

Product category

Pharmaceutical Cannabis Manufacturing

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

Keywords

• Medical cannabis manufacturing
• Pharmaceutical contract manufacturing
• CBD wellness products
• White label CBD production
• Cannabis extraction services

Headquarters

HQ city

Skopje 1000

HQ country

North Macedonia

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Infrastructure, Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. CDMO/Contract Manufacturing Services: Provides comprehensive CDMO (Contract Development and Manufacturing Organization) services including GACP/GMP conversion, product development, custom formulations, processing, and packaging for pharmaceutical and medicinal industries. Charges for processing services and primary & secondary packaging for flower, extracts, distillate, and isolates under EU-GMP standards.
2. White and Private Label Production: Production of white and private label Hemp and CBD products for clients in Europe and Asia. Partners with clients to create high-quality white and private label products, offering formulation, design, packaging, compliance, testing, and certification services.
3. Consumer CBD Products (Herbliz Brand): Direct-to-consumer sales of CBD oils, wellness products, cosmetics, vapes, and hemp products through the Herbliz brand (herbliz.com). Products include CBD oils, bath additives, facial creams, Beauty Booster, Beauty Balms, and vape pens.
4. Herbliz Supplements: Production and sale of nutritional supplements including melatonin drops and HERBLIZ vitamin series based on liposomal technology for enhanced bioavailability.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

New Garden Pharma operates an EU GMP-certified medical cannabis extraction and processing facility in Skopje, North Macedonia, converting GACP starting material into EU-GMP compliant cannabis API and FDF. The company offers CDMO services including CO2 extraction, distillation, product development, custom formulations, stability studies, quality control, and primary/secondary packaging for pharmaceutical and medicinal industries across Europe.

Product overview

New Garden Group operates as a vertically integrated cannabis company with three main divisions: New Garden Pharma (EU GMP certified medical cannabis extraction and processing facility in North Macedonia), Herbliz Berlin (wellness CBD brand offering oils, cosmetics, vapes and hemp products), and Herbliz Whitelabel (ISO-certified white/private label manufacturing in Berlin). The company's manufacturing capabilities include CO2 extraction, distillation, processing and packaging of cannabis API, FDF, flowers, extracts, distillates and isolates. Herbliz Supplements, the newest brand, offers nutritional supplements with proprietary liposomal technology for enhanced bioavailability. The group serves pharmaceutical, medicinal, and wellness industries across Europe, providing both branded consumer products and B2B manufacturing services.

Differentiator

Problem solved

Functional benefit

Brands

• New Garden Pharma: EU GMP extraction and processing facility for medical cannabis - produces API and FDF solutions from cannabis flowers and extracts
• Herbliz Berlin
• Herbliz Whitelabel
• Herbliz Supplements

Products and services

• Medical Cannabis Extracts Natural, pure, and high-quality medical cannabis extracts produced using advanced CO2 technology with no harmful solvents or residue, for pharmaceutical and medicinal industry buyers.
• Full-Spectrum Distillates High-end distillation products enriched with selected natural terpenes for pharmaceutical and medicinal applications.
• Cannabis Isolates Pure cannabinoid isolates processed and packaged under EU-GMP standards.
• Cannabis API (Active Pharmaceutical Ingredients) Premium, quality-assured cannabis Active Pharmaceutical Ingredients produced through CO2 extraction and meticulous processing techniques under EU-GMP standards.
• Cannabis FDF (Final Dosage Forms) Final dosage forms sourced from premium cannabis flowers and extracts, processed under EU-GMP standards.
• NGP-flower EU-GMP graded cannabis flower product processed at the Skopje facility, available for NGP partners or client-provided flower.
• CDMO Services Contract development and manufacturing organization services including stability studies, quality control, processing and packaging for flowers, extracts, distillates, and isolates under EU-GMP standards.
• Herbliz CBD Oils CBD oils obtained from hemp flower and leaf extracts containing high CBD levels, available in various spectrums for individual consumers.
• Herbliz CBD Cosmetics Facial creams, Beauty Booster and Beauty Balms with soothing, balancing, and sebum-regulating effects on sensitive and stressed skin for individual consumers.
• Herbliz CBD Vapes Vape pens with ceramic head for gentle evaporation of pure and authentic CBD aroma, promoting inner clarity, balance and relaxation for individual consumers.
• Herbliz Hemp Cosmetics Organic hemp beauty products for all skin types, featuring moisturizing hemp oil with fatty acids like gamma-linolenic acid for individual consumers.
• Herbliz CBD Wellness CBD wellness products including bath additives and products supporting relaxation for individual consumers.
• White Label CBD Products Pre-formulated CBD products available for rebranding and resale by white label customers in Europe and Asia.
• Private Label Formulation Services R&D experts generate custom formulations for private label brands considering customers' ideas, preferences, target groups, and market trends for B2B clients.
• Herbliz Melatonin Drops Liposomal melatonin supplement drops designed for inner balance and relaxation using natural ingredients for individual consumers.
• Herbliz Vitamin Series Vitamin supplements including VitC, Q10, Omega, OPC, and Melatonin, formulated with liposomal technology for enhanced bioavailability and faster, longer-lasting effect for individual consumers.

Quantifiable outcome

• Up to 22-fold increased bioavailability for fat-soluble active ingredients using liposomal technology
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Aurora Cannabis: Canadian-headquartered cannabis major with EU GMP-certified production in Germany and Denmark, supplying medical cannabis APIs and competing for European pharmaceutical tenders.
• Canopy Growth: Global cannabis operator with European medical cannabis activities through its German subsidiary, overlapping with NGP's medical cannabis API/FDF target market.
• Tilray Brands: Large multi-jurisdiction cannabis operator with established EU GMP operations supplying medical cannabis APIs and finished products across Europe, representing scale competition for NGP's CDMO bid.

Direct peers

• Sanity Group: Berlin-based vertically integrated cannabis operator combining medical cannabis production with consumer CBD/wellness brands — same integrated model and geographic footprint as New Garden Group.
• Demecan: German medical cannabis cultivator and processor with EU GMP-equivalent operations, directly competing for the same pharmaceutical-grade API/FDF customers in Germany and broader Europe that NGP targets.
• Four 20 Pharma: German medical cannabis producer and distributor operating GMP-grade manufacturing and supplying pharmacies across Europe, directly comparable to NGP's medical cannabis API and FDF offering.
• Cannamedical: German medical cannabis company focused on EU GMP-certified processing and pharmacy distribution of cannabis APIs, closely aligned with NGP's CDMO and wholesale activities in Germany.
• Cantourage: European medical cannabis distribution and processing platform that partners with GMP-certified producers to bring flower and extracts to German and UK pharmacies, comparable in scale and channel focus.

Emerging players

• Endoca: European (Denmark-based) CBD wellness brand producing hemp extracts, oils, and cosmetics, comparable to Herbliz Berlin's consumer CBD portfolio.
• Naturecan: UK-based CBD and wellness brand selling CBD oils, cosmetics, and supplements online across Europe, comparable to Herbliz Berlin's direct-to-consumer channel strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/new-garden-pharma

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Garden Pharma